Christoph C. Zielinski – författare
Visar alla böcker från författaren Christoph C. Zielinski. Handla med fri frakt och snabb leverans.
5 produkter
Drugs for HER-2-positive Breast Cancer
Av Maria Sibilia, Christoph C. Zielinski m. fl.
Inbunden, 2011
1688 kr
Lägg i varukorg
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the …
Drugs for HER-2-positive Breast Cancer
Av Thomas W. Grunt, Rupert Bartsch m. fl.
E-bok, 2011
2174 kr
Lägg i varukorg
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the …
Drugs for HER-2-positive Breast Cancer
Av Maria Sibilia, Christoph C. Zielinski m. fl.
Häftad, 2013
1688 kr
Lägg i varukorg
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the …
Systemic Lupus Erythematosus
Clinical and Experimental Aspects
Av Christoph C. Zielinski, Josef S. Smolen
E-bok, 2012
1502 kr
Lägg i varukorg
More than 140 years ago, lupus erythematosus (LE) was recognized as a disease entity by clinicians working in the field of dermatology, which had only recently become an independent medical discipline. Soon after cutaneous lupus was first reported, it was realized that, apart from the skin, the …
Systemic Lupus Erythematosus
Clinical and Experimental Aspects
Av Josef S. Smolen, Christoph C. Zielinski
Häftad, 2011
1128 kr
Lägg i varukorg
More than 140 years ago, lupus erythematosus (LE) was recognized as a disease entity by clinicians working in the field of dermatology, which had only recently become an independent medical discipline. Soon after cutaneous lupus was first reported, it was realized that, apart from the skin, the …
